PUBLISHER: The Business Research Company | PRODUCT CODE: 1946681
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946681
Orthopedic bone cement is a medical adhesive used during orthopedic surgeries to stabilize and secure implants inside the body, including artificial joints and bone fragments. It is widely applied in procedures such as hip and knee replacements to strengthen the connection between the implant and bone, supporting proper healing and long-term stability.
The main types of orthopedic bone cement include low-viscosity cement, medium-viscosity cement, and high-viscosity cement. Low-viscosity bone cements have a thinner and more fluid consistency, allowing easy penetration into small bone cavities and providing uniform coverage around implants during surgery. The material types include polymethyl methacrylate (PMMA), ceramic, acrylic, and others, and the end users include hospitals, orthopedic clinics and centers, and others.
Tariffs have raised procurement costs for PMMA and specialty additives used in orthopedic bone cement, impacting hospitals and orthopedic clinics dependent on imported materials. Europe and Asia-Pacific manufacturing chains are most affected. On the positive side, tariffs are accelerating domestic manufacturing, improving supply security, and promoting innovation in cost-efficient cement formulations.
The orthopedic bone cement market research report is one of a series of new reports from The Business Research Company that provides orthopedic bone cement market statistics, including orthopedic bone cement industry global market size, regional shares, competitors with a orthopedic bone cement market share, detailed orthopedic bone cement market segments, market trends and opportunities, and any further data you may need to thrive in the orthopedic bone cement industry. This orthopedic bone cement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The orthopedic bone cement market size has grown strongly in recent years. It will grow from $1.05 billion in 2025 to $1.11 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increase in hip and knee replacements, widespread use of PMMA, aging population, hospital-based orthopedic surgeries, surgeon familiarity with cemented fixation.
The orthopedic bone cement market size is expected to see strong growth in the next few years. It will grow to $1.4 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to growth in revision surgeries, demand for infection-resistant materials, rising trauma cases, technological improvements in cement formulations, expansion of outpatient orthopedic centers. Major trends in the forecast period include growing preference for high viscosity cements, rising demand in joint replacement surgeries, adoption of antibiotic-loaded bone cements, shift toward ready-to-use cement formats, emphasis on faster surgical procedures.
The increasing incidence of accidents and injuries is increasingly supporting the expansion of the orthopedic bone cement market going forward. The rise in accidents and injuries is associated with higher traffic density, greater participation in high-risk activities, distracted driving behaviors, and insufficient safety measures. Orthopedic bone cement plays a critical role in injury treatment by securing implants and supporting the repair of fractures and damaged joints, thereby ensuring structural stability and promoting proper healing. For example, in December 2023, according to the World Health Organization, approximately 1.19 million people die each year due to road traffic accidents, while 20 to 50 million individuals sustain non-fatal injuries, many resulting in long-term disabilities. As a result, the growing number of accidents and injuries is strengthening the orthopedic bone cement market.
Leading companies operating in the orthopedic bone cement market are focusing on developing innovative products, such as antibiotic-loaded spacers, to improve infection control during joint replacement procedures and enhance patient outcomes. Antibiotic-loaded spacers are temporary implants made from bone cement infused with antibiotics, commonly used in the treatment of infected joint prostheses. For example, in November 2023, Biocomposites Ltd., a UK-based medical device company, launched SYNICEM hip, knee, and shoulder preformed spacers. These antibiotic-loaded spacers are designed to maintain joint space, deliver high local concentrations of gentamicin, and provide consistent structural performance, supporting effective infection management during joint revision surgeries.
In January 2024, Enovis, a US-based medical technology company specializing in orthopedic products and services, acquired LimaCorporate for an undisclosed amount. This acquisition enhances Enovis's orthopedic portfolio, particularly in joint reconstruction, by adding innovative implant technologies. LimaCorporate is an Italy-based provider of bone cement products.
Major companies operating in the orthopedic bone cement market are Johnson & Johnson Services Inc, 3M Company, Stryker Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc, Smith & Nephew plc, Enovis Corporation, Wright Medical Group N.V, Medacta International SA, Exactech Inc, Tecres S.p.A, Heraeus Medical GmbH, Graftys SA, TEKNIMED SAS, Merit Medical Systems, OSARTIS GmbH, IZI Medical, Shanghai Rebone, SetBone Medical Ltd, curasan AG, Osseon, Cambridge Polymer Group Inc, BioMedtrix, Noblus, Surgical Specialties Corporation, Orthoplastics, Evolutis, Groupe Lepine, Synimed
North America was the largest region in the orthopedic bone cement market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the orthopedic bone cement market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the orthopedic bone cement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The orthopedic bone cement market consists of sales of antibiotic-loaded bone cement, calcium phosphate cement, biodegradable bone cement, and bone void fillers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Orthopedic Bone Cement Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses orthopedic bone cement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for orthopedic bone cement ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The orthopedic bone cement market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.